Australia markets closed

NeuroBo Pharmaceuticals, Inc. (NRBO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.1400+0.0800 (+2.61%)
At close: 04:00PM EDT
3.1000 -0.04 (-1.27%)
After hours: 05:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
4,470
9,158
2,778
6,546
21,870
Selling general and administrative
9,306
6,728
8,640
8,752
7,846
Total operating expenses
13,776
15,886
11,418
15,298
29,716
Operating income or loss
-13,776
-15,886
-11,418
-15,298
-29,716
Interest expense
0
0
2,191
0
-
Total other income/expenses net
2,955
2,955
-358
-
-1
Income before tax
-13,869
-12,470
-13,967
-15,284
-29,678
Income tax expense
0
0
0
0
0
Income from continuing operations
-13,869
-12,470
-13,967
-15,284
-29,678
Net income
-13,869
-12,470
-13,967
-15,284
-29,678
Net income available to common shareholders
-13,869
-12,470
-13,967
-15,284
-29,678
Basic EPS
-43.82
-
-43.42
-158.48
-439.20
Diluted EPS
-43.82
-
-43.42
-158.48
-439.20
Basic average shares
3,826
-
321.703
96.427
67.572
Diluted average shares
3,826
-
321.703
96.427
67.572